✦ LIBER ✦

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Patients With Heart Failure and Systolic Dysfunction

✍ Scribed by James E. Udelson; Martin Bilsker; Paul J. Hauptman; Rafael Sequeira; Ignatius Thomas; Terrence O’Brien; Christopher Zimmer; Cesare Orlandi; Marvin A. Konstam

Book ID: 116341390
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 169 KB
Volume: 17
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2011.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter, Randomized, Double-Blind, P

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study on the Effect of Oral Tolvaptan on Left Ventricular Dilation and Function in Patients With Heart Failure and Systolic Dysfunction

✍ James E. Udelson; Frank A. McGrew; Enrique Flores; Hassan Ibrahim; Stewart Katz; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 519 KB

Rationale and Design of the Multicenter,

Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)

✍ Mihai Gheorghiade; Cesare Orlandi; John C. Burnett Jr.; David DeMets; Liliana Gr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Acute Hemodynamic Effects of Tolvaptan,

Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction: An International, Multicenter, Randomized, Placebo-Controlled Trial

✍ James E. Udelson; Cesare Orlandi; John Ouyang; Holly Krasa; Christopher A. Zimme 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Acute Hemodynamic Effects of Tolvaptan,

Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients with Symptomatic Heart Failure and Systolic Dysfunction: The ECLIPSE International, Multicenter, Randomized, Placebo-controlled Trial

✍ James E. Udelson; Cesare Orlandi; John Ouyang; Holly Krasa; Christopher A. Zimme 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Rationale and study design for a multice

Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure

✍ Mihai Gheorghiade; Wendy A. Gattis; Alejandro Barbagelata; Kirkwood F. Adams Jr; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 76 KB

The ACCLAIM Trial: A Multicenter, Random

The ACCLAIM Trial: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Immune Modulation Therapy in Patients with Heart Failure due to Systolic Left Ventricular Dysfunction

✍ Guillermo Torre-Amione 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 85 KB